|
1. FDA approves pancreatic cancer drug that nearly doubles survival Full story
2. Cost Plus Drugs joins pediatric cancer trial partnership Full story
3. This cancer center’s infusion capacity was maxed out. Then it grew volume and cut wait times — without adding space. See how here.
4. Dana-Farber names operations, infrastructure leader Full story
5. The clinical trial problem cancer groups want HHS to fix Full story
6. Fred Hutch names 2 endowed chairs Full story
7. Moffitt launches radiopharmaceutical program Full story
8. Federal vs. industry-sponsored cancer clinical trials: 7 notes Full story
9. UMC New Orleans expands cancer center Full story
10. Allegheny Health Network to launch early phase clinical trials Full story
Becker’s Learning Opportunities
11. Pushing cancer research forward without federal backing is the question every academic cancer center is asking, and the leaders answering it are at Becker’s Fall Oncology Executive Summit Nov. 4-5 in Chicago. Apply to attend as a reviewer here.
12. Longer, more complex cancer treatment journeys demand support between visits. Learn scalable models in this webinar.
13. Essentia Health’s infusion and oncology director on pharmacy’s revenue blind spot in this webinar.
14. Becker’s late-August webinar lineup: patient safety, referral intake, AI trust and supply chain data. See the sessions here.
|
.png)
